NCT00479986View on ClinicalTrials.gov

Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

June 30, 2005

Study Completion Date

November 30, 2006

Conditions
Type 2 Diabetes MellitusCardiovascular Disease
Interventions
DRUG

pioglitazone

DRUG

placebo

Trial Locations (2)

55116

IKFE, Mainz

Unknown

Dr. Michael Morcos, Heidelberg

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

collaborator

Johannes Gutenberg University Mainz

OTHER

collaborator

Heidelberg University

OTHER

lead

IKFE Institute for Clinical Research and Development

OTHER